Association of venetoclax-based therapy with increased survival in multiple myeloma (MM) harboring t(11;14): A single-center experience

被引:0
作者
Ionescu, Filip
Patel, Parth
Thapa, Shrinjaya
Drekolias, Dimitrios
Blue, Brandon Jamaal
Puglianini, Omar Alexis Castaneda
Ochoa-Bayona, Jose L.
Freeman, Ciara L.
Liu, Hien
Hansen, Doris K.
Nishihori, Taiga
Silva, Ariosto
Sudalagunta, Praneeth Reddy
Brayer, Jason B.
Alsina, Melissa
Shain, Kenneth H.
Baz, Rachid C.
Grajales-Cruz, Ariel Felipe
机构
[1] H Lee Moffitt Canc Ctr & Res Inst, Tampa, FL USA
[2] Univ S Florida, Tampa, FL USA
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
e20055
引用
收藏
页数:1
相关论文
共 50 条
  • [31] Racial Differences in Molecular Cytogenetic Abnormalities in Black and White Patients with Multiple Myeloma (MM): A Single-Center Experience
    Zou, Ying S.
    Huang, Yi
    Feng, Zhou
    Chan, Sin
    Shukla, Shweta
    Lee, Ina
    Singh, Zeba
    Kocoglu, Mehmet H.
    Rapoport, Aaron P.
    Ma, Ning
    Hardy, Nancy M.
    Yared, Jean
    Baer, Maria R.
    Badros, Ashraf Z.
    BLOOD, 2015, 126 (23)
  • [32] Autologous stem cell transplantion (ASCT) for multiple myeloma (MM) with selected graft: A single-center experience.
    Wattad, M
    Baur, FK
    Delfs, C
    Balleisen, L
    Heit, W
    BLOOD, 2001, 98 (11) : 401B - 401B
  • [33] Phase 1 Study of Venetoclax in Combination with Dexamethasone As Targeted Therapy for t(11;14) Relapsed/Refractory Multiple Myeloma
    Kaufman, Jonathan L.
    Gasparetto, Cristina J.
    Mikhael, Joseph
    Moreau, Philippe
    Touzeau, Cyrille
    Vij, Ravi
    Facon, Thierry
    Pegourie, Brigitte
    Benboubker, Lofti
    Boise, Lawrence H.
    Alzate, Stefanie
    Dunbar, Martin
    Jia, Jia
    Freise, Kevin J.
    Verdugo, Maria
    Ross, Jeremy
    Maciag, Paulo
    Kumar, Shaji K.
    BLOOD, 2017, 130
  • [34] Targeted Venetoclax Therapy in t(11;14) Multiple Myeloma: Real World Data From Seven Hungarian Centers
    Szita, Virag Reka
    Mikala, Gabor
    Kozma, Andras
    Fabian, Janos
    Hardi, Apor
    Alizadeh, Hussain
    Rajnics, Peter
    Rejto, Laszlo
    Szendrei, Tamas
    Varoczy, Laszlo
    Nagy, Zsolt
    Illes, Arpad
    Valyi-Nagy, Istvan
    Masszi, Tamas
    Varga, Gergely
    PATHOLOGY & ONCOLOGY RESEARCH, 2022, 28
  • [35] A retrospective single-center experience with bortezomib-based therapy of relapsed and/or refractory multiple myeloma: survival results of our first 104 consecutive patients
    Mikala, G.
    Batai, A.
    Bodo, I.
    Csukly, Z.
    Dolgos, J.
    Halm, G.
    Janosi, J.
    Kapas, B.
    Lovas, N.
    Lueff, S.
    Peto, M.
    Remenyi, P.
    Sipos, A.
    Toth, Z.
    Masszi, T.
    BLOOD REVIEWS, 2007, 21 : S73 - S74
  • [36] Early Relapse for Multiple Myeloma Patients Undergoing Single Autologous Stem Cell Therapy: A Single-center Experience
    Lee, Holly
    Duggan, Peter
    Chaudhry, Ahsan
    Neri, Paola
    Tay, Jason
    Rashid-Kolvear, Fariborz
    Bahlis, Nizar J.
    Jimenez-Zepeda, Victor H.
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2018, 18 (01) : E69 - E75
  • [37] Single-center Experience in Treating Patients With t(4;14) Multiple Myeloma With and Without Planned Frontline Autologous Stem Cell Transplantation
    Chan, Henry
    Phillips, Madeline
    Maganti, Manjula
    Farooki, Sophia
    Rodriguez, Giovanni Piza
    Masih-Khan, Esther
    Chen, Christine
    Prica, Anca
    Reece, Donna
    Tiedemann, Rodger
    Trudel, Suzanne
    Kukreti, Vishal
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2018, 18 (03) : 225 - 234
  • [38] Pomalidomide-based therapy in Relapsed/Refractory Multiple Myeloma: a real-world single-center experience.
    Fucci, Ludovica
    Fiori, Luciano
    Coppetelli, Ugo
    Cimino, Giuseppe
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2021, 21 : S144 - S145
  • [39] A Favorable BCL-2 Family Expression Profile May Explain the Increased Susceptibility of the t(11;14) Multiple Myeloma Subgroup to Single Agent Venetoclax
    Wu, Jenny
    Ross, Jeremy
    Peale, Franklin V., Jr.
    Shaughnessy, John D., Jr.
    Van Laar, Ryan K.
    Morgan, Gareth J.
    Venstrom, Jeffrey M.
    Punnoose, Elizabeth A.
    BLOOD, 2016, 128 (22)
  • [40] Genetic Abnormalities in a Real-World Cohort of Multiple Myeloma (MM) Patients, and Their Impact on Outcomes: Single-Center Experience
    Vaitekenaite, Vilmante
    Peceliunas, Valdas
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2023, 23 : S499 - S500